Lepu Biopharma Future Growth
Future criteria checks 2/6
Lepu Biopharma is forecast to grow revenue at 51.7% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 35.1% |
| Revenue growth rate | 51.7% |
| Future return on equity | -65.1% |
| Analyst coverage | Low |
| Last updated | 07 May 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 989 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 270 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 280 | N/A | N/A | N/A | 1 |
| 12/31/2023 | 225 | -22 | -292 | -251 | N/A |
| 9/30/2023 | 197 | -254 | -366 | -307 | N/A |
| 6/30/2023 | 169 | -487 | -440 | -364 | N/A |
| 3/31/2023 | 92 | -588 | -518 | -422 | N/A |
| 12/31/2022 | 16 | -689 | -596 | -481 | N/A |
| 9/30/2022 | 8 | -766 | -617 | -471 | N/A |
| 6/30/2022 | N/A | -843 | -638 | -460 | N/A |
| 3/31/2022 | N/A | -927 | -740 | -541 | N/A |
| 12/31/2021 | N/A | -1,011 | -841 | -622 | N/A |
| 12/31/2020 | N/A | -582 | -734 | -423 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2157's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if 2157's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 2157's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2157's revenue (51.7% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).
High Growth Revenue: 2157's revenue (51.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2157 is forecast to be unprofitable in 3 years.